Healthcare provider profile · identity verified

Kenneth A Young, M.D.

Family Practice · WHITELAND, IN · NPI 1437150067

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	769	223
Levothyroxine Sodium	Levothyroxine Sodium	364	96
Amlodipine Besylate	Amlodipine Besylate	363	105
Lisinopril	Lisinopril	346	96
Metoprolol Succinate	Metoprolol Succinate	336	93
Metformin Hcl	Metformin Hcl	199	61
Ezetimibe	Ezetimibe	186	46
Omeprazole	Omeprazole	186	52
Albuterol Sulfate Hfa	Albuterol Sulfate	158	43
Glipizide Er	Glipizide	144	38
Citalopram Hbr	Citalopram Hydrobromide	135	40
Pantoprazole Sodium	Pantoprazole Sodium	132	40
Gabapentin	Gabapentin	131	39
Pravastatin Sodium	Pravastatin Sodium	125	34
Meloxicam	Meloxicam	122	39
Rosuvastatin Calcium	Rosuvastatin Calcium	115	29
Metoprolol Tartrate	Metoprolol Tartrate	114	31
Alendronate Sodium	Alendronate Sodium	113	37
Duloxetine Hcl	Duloxetine Hcl	110	24
Furosemide	Furosemide	108	31
Allopurinol	Allopurinol	104	28
Alprazolam	Alprazolam	100	18
Montelukast Sodium	Montelukast Sodium	100	28
Losartan Potassium	Losartan Potassium	93	30
Tamsulosin Hcl	Tamsulosin Hcl	92	33
Hydrochlorothiazide	Hydrochlorothiazide	77	25
Carvedilol	Carvedilol	76	21
Zolpidem Tartrate	Zolpidem Tartrate	76	13
Fluoxetine Hcl	Fluoxetine Hcl	67	19
Hydrocortisone	Hydrocortisone	65	29
Eliquis	Apixaban	64	15
Venlafaxine Hcl Er	Venlafaxine Hcl	63	17
Azithromycin	Azithromycin	62	53
Cephalexin	Cephalexin	62	48
Raloxifene Hcl	Raloxifene Hcl	62	20
Sertraline Hcl	Sertraline Hcl	62	24
Simvastatin	Simvastatin	60	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Trazodone Hcl	Trazodone Hcl	57	12
Doxazosin Mesylate	Doxazosin Mesylate	50	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	17
Januvia	Sitagliptin Phosphate	49	14
Clopidogrel	Clopidogrel Bisulfate	46	16
Diclofenac Sodium	Diclofenac Sodium	46	13
Fluticasone Propionate	Fluticasone Propionate	46	18
Tramadol Hcl	Tramadol Hcl	43	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	35
Spironolactone	Spironolactone	40	14
Jardiance	Empagliflozin	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Potassium Chloride	Potassium Chloride	35	15
Atenolol	Atenolol	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Famotidine	Famotidine	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Lovastatin	Lovastatin	33	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Ondansetron Odt	Ondansetron	30	13
Doxepin Hcl	Doxepin Hcl	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Prednisone	Prednisone	28	suppressed
Valsartan	Valsartan	28	suppressed
Methylprednisolone	Methylprednisolone	27	23
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	11
Clonidine Hcl	Clonidine Hcl	26	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	25	25
Advair Hfa	Fluticasone Propion/Salmeterol	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Diazepam	Diazepam	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	20
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	16
Acyclovir	Acyclovir	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	19	19
Finasteride	Finasteride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	14
Fenofibrate	Fenofibrate	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Fluconazole	Fluconazole	16	suppressed
Glipizide	Glipizide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Ozempic	Semaglutide	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Primidone	Primidone	13	suppressed
Temazepam	Temazepam	13	suppressed
Estradiol	Estradiol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Indapamide	Indapamide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Nystatin	Nystatin	12	suppressed
Ramipril	Ramipril	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error